Revenue
2022
2023
2024
2025
Faeth Therapeutics, Inc. (FTH)
Price$40.05Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — |
| Research & development | $11.0M | $18.6M | $18.3M | $30.4M | — | — |
| Operating expenses | $22.3M | $32.6M | $37.1M | $50.2M | $37.5M | $19.5M |
| Operating income | −$22.3M | −$32.6M | −$37.1M | −$50.2M | −$37.5M | −$19.5M |
| EBITDA | −$22.2M | −$32.1M | −$36.5M | −$49.6M | −$36.8M | −$19.2M |
| Net income | −$21.1M | −$30.2M | −$34.1M | −$48.6M | −$36.8M | −$20.1M |
| Basic EPSper basic share | -$16.72 | -$24.01 | -$24.40 | -$31.60 | -$26.60 | -$250.60 |
| Diluted EPSper diluted share | -$16.72 | -$24.01 | -$24.40 | -$31.60 | -$26.60 | -$250.60 |
Owners
Reported shareholders
7.82%of listed shares
MONTANOVA CAPITAL, LLC2.02M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
MONTANOVA CAPITAL, LLC | 7.82%2.02M shares |
Avoro Capital Advisors LLC | 5.59%1.44M shares |
BAKER BROS. ADVISORS LP | 4.98%1.29M shares |
Balyasny Asset Management L.P. | 4.03%1.04M shares |
Cormorant Asset Management, LP | 3.98%1.03M shares |
Parikh Anand Kiran | ≈3.17%817.7K shares |
RA CAPITAL MANAGEMENT, L.P. | 2.79%722.02K shares |
Vivo Capital, LLC | 2.79%722.02K shares |
Logos Global Management LP | 2.79%722.02K shares |
Fairmount Funds Management LLC | 2.79%722.02K shares |
Caligan Partners LP | 2.44%629.47K shares |
B Group, Inc. | 2.36%610.17K shares |
Trails Edge Capital Partners, LP | 1.99%515.34K shares |
FRANKLIN RESOURCES INC | 1.91%494.52K shares |
Octagon Capital Advisors LP | 1.40%361.01K shares |
ADAR1 Capital Management, LLC | 1.40%361.01K shares |
MARSHALL WACE, LLP | 0.80%206.51K shares |
Boxer Capital Management, LLC | 0.70%180.51K shares |
Patient Square Capital LP | 0.68%175.05K shares |
Alyeska Investment Group, L.P. | 0.56%144.4K shares |
Percentages use 25.83M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026Form 4 | STEPHENSON BRIAN CChief Financial Officer | BuyCommon Stock · indirect | 100 | $26.39 | $2.6K | 33.1K |
| Jun 26, 2026Form 4 | STEPHENSON BRIAN CChief Financial Officer | BuyCommon Stock · indirect | 1.4K | $25.55 | $34.7K | 33.0K |
| Jun 26, 2026Form 4 | STEPHENSON BRIAN CChief Financial Officer | BuyCommon Stock · indirect | 4.2K | $24.90 | $104.9K | 31.6K |
| Jun 26, 2026Form 4 | STEPHENSON BRIAN CChief Financial Officer | BuyCommon Stock · indirect | 580 | $23.61 | $13.7K | 27.4K |
| Jun 24, 2026Form 4 | STEPHENSON BRIAN CChief Financial Officer | BuyCommon Stock · indirect | 100 | $27.77 | $2.8K | 26.8K |